| News
Superlab Suisse heading to Basel
05.04.2022
Superlab Suisse is bringing its Lab-as-a-Service business concept to Basel. The company will open a new location with lab and research space in the beginning of 2024 at the city’s Stücki Park.

Superlab Suisse will offer laboratories in Basel (img: Superlab Suisse)
Superlab Suisse is establishing a presence in Basel. Founded in 2019, the Zurich-based firm will be offering its laboratory services from Stücki Park in Basel. Superlab Suisse will have one high rise building with lab and research space covering an area of 6,200 square meters at the Innovation Center for Life Sciences in Stuecki Park Basel North.
The Superlab Suisse business concept is directed towards biotechnology, pharmaceutical and medtech companies, and encompasses lab facilities, state-of-the-art equipment, professional and concierge services as well as financing support. “These companies should have to worry as little as possible about infrastructure, allowing them instead to focus their investments entirely on research and innovation”, comments CEO Zhang Xi.
Entire life sciences value chain available
Superlab Suisse already has laboratories based in Lausanne and in 2024 also in Schlieren in the canton of Zurich. The company now also has its sights set on tapping into one of the most important life sciences clusters in Europe and around the world. As the company explains, the entire life sciences value chain can be found in the Basel Area. This ranges from research and startups all the way through to manufacturing, commercialization and distribution activities. Therefore, there is a “large talent pool of experienced specialists, suppliers and service providers at every stage and for every function of your company”.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
KUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read MoreCell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read MoreInvestors give Resistell 8.5 million Swiss francs
Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read More